Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Jan;64(1):55–60. doi: 10.1128/iai.64.1.55-60.1996

Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine.

B T Bosworth 1, J E Samuel 1, H W Moon 1, A D O'Brien 1, V M Gordon 1, S C Whipp 1
PMCID: PMC173727  PMID: 8557374

Abstract

Escherichia coli strains producing Shiga-like toxin II variant (SLT-IIe, formerly called SLT-IIv) cause edema disease in weaned pigs. Vaccination of pigs with a genetically modified form of Shiga-like toxin IIe, SLT-IIe(E167Q), has been previously shown to be nontoxic and to induce antibodies to SLT-IIe (V.M. Gordon. S.C. Whipp, H.W. Moon, A.D. O'Brien, and J.E. Samuel, Infect, Immun. 60:485-502, 1992). Fifty micrograms of SLT-IIe(E167Q) toxin was used to vaccinate suckling pigs at 1 and 2 weeks of age. Both vaccinated and nonvaccinated pigs were orally inoculated with an SLT-IIe-producing strain of E. coli after weaning (3 to 4 weeks of age). Pigs fed a low-protein diet that were not vaccinated with SLT-IIe(E167Q) developed subclinical edema disease, histologically evident as vascular necrosis. Pigs fed a high-protein diet that were not vaccinated with SLT-IIe(E167Q) developed clinical edema disease manifested as vascular necrosis, reduced weight gain, ataxia, palpebral edema, lateral recumbency, and death. Pigs vaccinated with SLT-IIe(E167Q) had a reduction in the incidence of subclinical edema disease and never developed clinical edema disease. These data demonstrate that vaccination with a genetically modified form of SLT-IIe prevents edema disease and are consistent with the notion that diet influences susceptibility to edema disease.

Full Text

The Full Text of this article is available as a PDF (191.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awad-Masalmeh M., Schuh M., Köfer J., Quakyi E. Uberprüfung der Schutzwirkung eines Toxoidimpfstoffes gegen die Odemkrankheit des Absetzferkels im Infektionsmodell. Dtsch Tierarztl Wochenschr. 1989 Sep;96(8):419–421. [PubMed] [Google Scholar]
  2. Bertschinger H. U., Bachmann M., Mettler C., Pospischil A., Schraner E. M., Stamm M., Sydler T., Wild P. Adhesive fimbriae produced in vivo by Escherichia coli O139:K12(B):H1 associated with enterotoxaemia in pigs. Vet Microbiol. 1990 Nov;25(2-3):267–281. doi: 10.1016/0378-1135(90)90083-8. [DOI] [PubMed] [Google Scholar]
  3. Bertschinger H. U., Stamm M., Vögeli P. Inheritance of resistance to oedema disease in the pig: experiments with an Escherichia coli strain expressing fimbriae 107. Vet Microbiol. 1993 May;35(1-2):79–89. doi: 10.1016/0378-1135(93)90117-P. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chanter N., Hall G. A., Bland A. P., Hayle A. J., Parsons K. R. Dysentery in calves caused by an atypical strain of Escherichia coli (S102-9). Vet Microbiol. 1986 Sep;12(3):241–253. doi: 10.1016/0378-1135(86)90053-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dobrescu L. New biological effect of edema disease principle (Escherichia coli-neurotoxin) and its use as an in vitro for this toxin. Am J Vet Res. 1983 Jan;44(1):31–34. [PubMed] [Google Scholar]
  6. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem. 1988 Jan 15;171(1-2):45–50. doi: 10.1111/j.1432-1033.1988.tb13756.x. [DOI] [PubMed] [Google Scholar]
  7. Gannon V. P., Gyles C. L., Wilcock B. P. Effects of Escherichia coli Shiga-like toxins (verotoxins) in pigs. Can J Vet Res. 1989 Jul;53(3):306–312. [PMC free article] [PubMed] [Google Scholar]
  8. Gordon V. M., Whipp S. C., Moon H. W., O'Brien A. D., Samuel J. E. An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect Immun. 1992 Feb;60(2):485–490. doi: 10.1128/iai.60.2.485-490.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HOWARD J. G. Observations on the intoxication produced in mice and rabbits by the neurotoxin of Shigella shigae. Br J Exp Pathol. 1955 Oct;36(5):439–446. [PMC free article] [PubMed] [Google Scholar]
  10. Hovde C. J., Calderwood S. B., Mekalanos J. J., Collier R. J. Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2568–2572. doi: 10.1073/pnas.85.8.2568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Imberechts H., de Greve H., Hernalsteens J. P., Schlicker C., Bouchet H., Pohl P., Charlier G., Bertschinger H. U., Wild P., Vandekerckhove J. The role of adhesive F107 fimbriae and of SLT-IIv toxin in the pathogenesis of edema disease in pigs. Zentralbl Bakteriol. 1993 Apr;278(2-3):445–450. doi: 10.1016/s0934-8840(11)80861-3. [DOI] [PubMed] [Google Scholar]
  12. Islam M. S., Stimson W. H. Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin. J Clin Lab Immunol. 1990 Sep;33(1):11–16. [PubMed] [Google Scholar]
  13. Johnson W. M., Lior H., Bezanson G. S. Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada. Lancet. 1983 Jan 1;1(8314-5):76–76. doi: 10.1016/s0140-6736(83)91616-1. [DOI] [PubMed] [Google Scholar]
  14. Karmali M. A., Petric M., Lim C., Fleming P. C., Arbus G. S., Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985 May;151(5):775–782. doi: 10.1093/infdis/151.5.775. [DOI] [PubMed] [Google Scholar]
  15. Karmali M. A., Steele B. T., Petric M., Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1983 Mar 19;1(8325):619–620. doi: 10.1016/s0140-6736(83)91795-6. [DOI] [PubMed] [Google Scholar]
  16. Kausche F. M., Dean E. A., Arp L. H., Samuel J. E., Moon H. W. An experimental model for subclinical edema disease (Escherichia coli enterotoxemia) manifest as vascular necrosis in pigs. Am J Vet Res. 1992 Mar;53(3):281–287. [PubMed] [Google Scholar]
  17. Kurtz H. J., Bergeland M. E., Barnes D. M. Pathologic changes in edema disease of swine. Am J Vet Res. 1969 May;30(5):791–806. [PubMed] [Google Scholar]
  18. MacLeod D. L., Gyles C. L. Immunization of pigs with a purified Shiga-like toxin II variant toxoid. Vet Microbiol. 1991 Nov;29(3-4):309–318. doi: 10.1016/0378-1135(91)90138-6. [DOI] [PubMed] [Google Scholar]
  19. Mainil J. G., Duchesnes C. J., Whipp S. C., Marques L. R., O'Brien A. D., Casey T. A., Moon H. W. Shiga-like toxin production and attaching effacing activity of Escherichia coli associated with calf diarrhea. Am J Vet Res. 1987 May;48(5):743–748. [PubMed] [Google Scholar]
  20. O'Brien A. D., Holmes R. K. Shiga and Shiga-like toxins. Microbiol Rev. 1987 Jun;51(2):206–220. doi: 10.1128/mr.51.2.206-220.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. O'Brien A. O., Lively T. A., Chen M. E., Rothman S. W., Formal S. B. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet. 1983 Mar 26;1(8326 Pt 1):702–702. doi: 10.1016/s0140-6736(83)91987-6. [DOI] [PubMed] [Google Scholar]
  22. Ogasawara T., Ito K., Igarashi K., Yutsudo T., Nakabayashi N., Takeda Y. Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli O157:H7 at the level of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes. Microb Pathog. 1988 Feb;4(2):127–135. doi: 10.1016/0882-4010(88)90054-x. [DOI] [PubMed] [Google Scholar]
  23. Samuel J. E., Perera L. P., Ward S., O'Brien A. D., Ginsburg V., Krivan H. C. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun. 1990 Mar;58(3):611–618. doi: 10.1128/iai.58.3.611-618.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Scotland S. M., Rowe B., Smith H. R., Willshaw G. A., Gross R. J. Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol. 1988 Apr;25(4):237–243. doi: 10.1099/00222615-25-4-237. [DOI] [PubMed] [Google Scholar]
  25. Sherwood D., Snodgrass D. R., O'Brien A. D. Shiga-like toxin production from Escherichia coli associated with calf diarrhoea. Vet Rec. 1985 Feb 23;116(8):217–218. doi: 10.1136/vr.116.8.217. [DOI] [PubMed] [Google Scholar]
  26. Smith H. W., Green P., Parsell Z. Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J Gen Microbiol. 1983 Oct;129(10):3121–3137. doi: 10.1099/00221287-129-10-3121. [DOI] [PubMed] [Google Scholar]
  27. Smith H. W., Halls S. The production of oedema disease and diarrhoea in weaned pigs by the oral administration of Escherichia coli: factors that influence the course of the experimental disease. J Med Microbiol. 1968 Aug;1(1):45–59. doi: 10.1099/00222615-1-1-45. [DOI] [PubMed] [Google Scholar]
  28. TIMONEY J. F. Oedema disease of swine. Vet Rec. 1950 Dec 9;62(49):748–756. doi: 10.1136/vr.62.49.748. [DOI] [PubMed] [Google Scholar]
  29. Wadolkowski E. A., Sung L. M., Burris J. A., Samuel J. E., O'Brien A. D. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun. 1990 Dec;58(12):3959–3965. doi: 10.1128/iai.58.12.3959-3965.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES